FP7H2020HORIZON
Bioneer A/S
- Country
- DKDenmark
- Defence projects
- 0
- Projects, all programmes
- 14
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 3,925,949
- Active
- 2008 to 2023
Projects
14 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| TOP-GUTTraining for Organoids modelling Physiology and Pathology in the human gastrointestinal tract | HORIZON | 2023 | Associated partner | EUR 0 |
| iP-OSTEOInduced pluripotent stem cell seeded active osteochondral nanofibrous scaffolds | H2020 | 2019 | Participant | EUR 9,200 |
| EBiSC2EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells | H2020 | 2019 | Participant | EUR 374,625 |
| ActiTOXActive organotypic models for nanoparticle toxicological screening | H2020 | 2019 | Participant | EUR 0 |
| circRTraincircular RNA Biology Training Network: from biogenesis to biomarkers | H2020 | 2017 | Partner | EUR 0 |
| TAT-CFNovel therapeutic approaches for the treatment of cystic fibrosis based on small molecule transmembrane anion transporters | H2020 | 2016 | Participant | EUR 557,375 |
| eCHO SystemsEnhancing CHO by Mammalian Systems Biotechnology (eCHO systems) | H2020 | 2015 | Partner | EUR 0 |
| EBISCEuropean Bank for induced pluripotent Stem Cells | FP7 | 2014 | Participant | EUR 895,623 |
| RNATRAINThe European non-coding RNA network | FP7 | 2013 | Participant | EUR 261,199 |
| CARTARDISIdentification and validation of novel pharmaceutical drug targets for cardiovascular disease | FP7 | 2013 | Participant | EUR 296,000 |
| STEMMADPatient-specific stem cell-derived models for Alzheimer’s disease and related neurodegenerative disorders | FP7 | 2013 | Participant | EUR 603,797 |
| COMPACTCollaboration on the Optimisation of Macromolecular Pharmaceutical Access to Cellular Targets | FP7 | 2012 | Participant | EUR 487,563 |
| BEST-STEM CELLSBiochemically Equivalent Substitutive Technology for Stem Cells | FP7 | 2009 | Participant | EUR 154,950 |
| EURONEUT-41EUROpean consortium on NEUTralising antibodies using gp41 | FP7 | 2008 | Participant | EUR 285,618 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.